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ABSTRACT
Many diseases commonly associated with aging are now thought to have social and 
physiologic antecedents in early life. Understanding how the timing of exposure to 
early life risk factors influences later-life health may illuminate mechanisms driving 
adult health inequalities and identify possible points for effective interventions. 
Recognizing chronic diseases as developing across the lifecourse also has implications 
for the conduct of research on adult risk factors for disease. We review alternative 
conceptual models that describe how the timing of risk factor exposure relates to the 
development of disease. We propose some expansions of lifecourse models to 
improve their relevance for research on adult chronic disease, using the relationship 
between education and adult cognitive decline and dementia as an example. 
We discuss the important implications each of the lifecourse conceptual models has 
on study design, analysis, and interpretation of research on aging and chronic 
diseases. We summarize several research considerations implied by the lifecourse 
framework, including: advantages of analyzing change in function rather than onset 
of impairment; the pervasive challenge of survivor bias; the importance of 
controlling for possible confounding by early life conditions; and the likely 
heterogeneity in responses of adults to treatment.
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INTRODUCTION
Accumulating evidence from lifecourse epidemiology indicates that many 
diseases typically diagnosed in adulthood have social and physiologic 
antecedents much earlier in life.1-3 Although the research faces many analytic 
challenges, the fundamental premise – illnesses of middle and late life are 
often shaped by developmental processes experienced in utero, in childhood, 
in adolescence or early adulthood – has strong empirical support.4-6 This 
result has several important implications for appropriate design, analysis, 
and interpretation of research on aging and chronic diseases. In many cases, 
an understanding of the role of early life conditions is relevant even for 
substantive research questions relating to exposures or outcomes exclusively 
encountered in adults. Research on adult chronic diseases focuses on 
identifying opportunities to intervene to improve population health, whether 
via clinical treatments, behavioral interventions, or policy changes. 
Understanding the lifecourse antecedents of diseases associated with aging 
can provide essential insight into selecting the timing and structure of 
interventions in order to successfully improve population health.7 Lifecourse 
epidemiology can both highlight new or unrecognized opportunities for 
improving population health and inform methods to test long-standing 
hypotheses about the determinants of adult disease. These models are also 
valuable for understanding the likely population health trends in a world 
undergoing a rapid demographic transformation. In some cases, lifecourse 
epidemiology suggests the stage was set for major population health changes 
decades ago, during the early lives of current cohorts of adults.
In this paper, we summarize the alternative etiologic models in lifecourse 
epidemiology, discuss limitations in the current literature, and propose 
some expansions of lifecourse models to improve their relevance for 
research on adult chronic disease. These models are important because 
paradigms for the development of adult disease shape the research questions 
we ask and the methods used to address such questions. Applying a life 
course perspective challenges researchers to consider the dynamic process 
and multidimensional nature of health and well-being in adulthood. After 
reviewing examples of such conceptual representations, we discuss several 
implications of these models for research on determinants of adult disease: 
the value of analyzing change in function rather than onset of impairment 
whenever possible; the pervasive challenge of survivor bias; the importance 
of controlling for possible confounding by early life conditions; and the 
likely heterogeneity in responses of adults to treatment.
For clarity, we illustrate our discussion with the example of the effects of 
education and cognitive stimulation on adult cognitive decline and dementia. 
Implications of Lifecourse Epidemiology 491
We consider possible benefits of education to be mediated by immersion in a 
cognitively stimulating environment, characterized by novelty and intellectual 
challenges, and assume that an individual may have such experiences at any 
time in life, via work or leisure activities, even if not participating in formal 
education. The possible effects of both educational attainment and adult 
cognitive engagement on dementia and cognitive decline are active research 
areas.8-11 The importance of lifecourse models for understanding cognitive 
aging and dementia has recently received increased attention.12-15 However, 
many of the ideas are immediately relevant to other outcomes, such as disability.
LIFECOURSE EPIDEMIOLOGY FRAMEWORKS
Fig. 1. Alternative lifecourse models linking the timing of exposure to stimulating 
cognitive environment and dementia risk. (a) Immediate risk; (b) Social trajectory; 
(c) Cumulative risk; (d) Early life latency; (e) Social mobility effects.
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Lifecourse epidemiology takes as a principle that, although many diseases 
are primarily diagnosed in old age, such conditions may nonetheless reflect 
damage (or benefits) incurred from exposures much earlier in life. Although 
the exact characterizations of alternative lifecourse models differ slightly 
across the published literature, researchers distinguish among competing 
models linking the timing of exposure to a potential risk factor to the 
manifestation of disease (Figure 1a-e).3,16 We use “risk factor” here to 
indicate an exposure or treatment that affects health, not merely a marker 
for such an exposure. For example we focus on exposures that would 
increase risk of disease for an individual who was exposed to the risk factor 
compared to the risk the individual would have had if he or she had not been 
exposed.17 The distinction between such a causal risk factor and proxies or 
markers for causal risk factors is that causal risk factors suggest opportunities 
for interventions to improve health, whereas changing markers or proxies 
for causal agents is not anticipated to provide health benefits.
Immediate effects models posit brief etiologic periods so that exposure 
to a causal risk factor increases risk of disease quite promptly.18 In other 
words, it assumes individuals experience a decrease in disease risk 
concurrently or shortly after the risk factor is removed. For example, Figure 
1a represents the assumption that low levels of cognitive stimulation in 
midlife immediately affect dementia risk, and educational or cognitive 
experiences in childhood or early adulthood are irrelevant. In this model, 
childhood education has no effect on dementia, either directly or mediated 
through adult cognitive experiences. Interventions to enrich the cognitive 
environments of children would not be expected to have any effect in this 
model, but late life interventions would be expected to be beneficial.
Many exposures, particularly those related to social position follow a 
“sticky” trajectory, where childhood conditions shape adult exposures. For 
these exposures, social trajectory models (Figure 1b) are more appropriate 
than immediate risk models. For example, high-quality childhood education 
may enable someone to obtain a challenging and engaging job, whereas 
poor childhood education may lead to monotonous work. In this case, if 
adult cognitive engagement affects dementia risk (as in the immediate risk 
model) then childhood education will also affect dementia risk via its 
influence on adult cognitive engagement. In Figure 1b, there is no direct 
effect of childhood exposure on adult outcomes, it is only the adult exposure 
that directly harms (or in this case, benefits) adult health. These cascading 
models are sometimes called “chain of risk” or “risk of risk” models. This 
model suggests there may be several options for designing effective 
interventions, because intervention in either childhood or adulthood could 
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be beneficial. To identify the most promising opportunities it is helpful to 
consider possible “elbow” or “lever” periods, when the intervention would 
have the largest effects on the exposure. Such “elbows” occur when the 
direction of future exposure trajectory is most malleable; possible turning 
points might occur during the first encounter with formal schooling, at the 
moment of transition from school to work, or at retirement.
In contrast to social trajectory models, which assume that early life 
social factors do not “get under the skin” but only increase risk of future 
damage, cumulative biological models posit that each period of risk factor 
exposure induces permanent physiologic harm (Figure 1c). This damage 
accumulates over the lifecourse, increasing risk of later illness with each 
additional exposure period. Even if the risk is removed in adulthood, the 
individual will still experience the physiologic damage accumulated prior 
to removal. Cumulative biological models often seem the most plausible 
description of risk-factor-health associations. Allostatic load models are 
premised on the accumulation of physical damage over the lifecourse.19,20 
Cumulative models may be especially apt for social risk factors. There are 
often many possible pathways via which social risk factors affect health, 
and different mechanisms may be relevant at different points in the 
pathway.21 However, physical toxins such as lead may also have cumulative 
biological effects on adult cognitive outcomes. For some diseases, including 
dementia, the diagnosis of the disease typically occurs long after the initial 
physiologic damage begins. The diagnosis is the tail end of a long, 
accumulating pathologic process. The cumulative biological model can 
also incorporate the concept of historically linked lives and intergenerational 
transfer of risk. Previous studies have suggested parental health and health 
behaviors have direct and early effects on their children, placing them at 
greater risk for subsequent detrimental health outcomes.22,23
For some exposures, there may be an especially sensitive window of 
time during which the exposure is extremely influential, and after the 
temporal window closes, the exposure is no longer relevant. Such sensitive 
period or latency models typically invoke a key developmental period. 
For  example, periods of rapid tissue growth, development of aspects of 
neurologic “architectural” structure,24-27 or plasticity in epigenetic marks28,29 
imply that environmental encounters during these periods will be unusually 
influential.30,31 A familiar example of a sensitive period is language 
development: humans are especially responsive to language exposure during 
early life.32 If there is no exposure during the sensitive age, full fluency is 
rarely achieved. Immigration studies suggest that many behavioral factors are 
developmentally sensitive as well.33 For example, the patterns of smoking 
among immigrant children depends on the age of immigration: early 
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immigrants are more likely to adopt the smoking patterns of the receiving 
culture (e.g., high smoking rates among American teenagers), while those 
who immigrate as adults are more likely to retain the smoking patterns of 
their country of origin.34,35 There is also evidence of possible early life 
critical period effects for specific adult physiological features. For example, 
adult obesity is associated with intrauterine environment and rapid weight 
gain in infancy.36,37
The final category of model, which we call a mobility effects model, 
explicitly addresses change as an exposure in and of itself (Figure 1e). 
For example, one may hypothesize that children successfully adapt to their 
early life conditions but those adaptations may be harmful if they encounter 
a different environment in adulthood (e.g., nutritional environment). 
Research on socioeconomic status sometimes posits that social mobility – 
whether up or down – is itself very stressful and results in worse health.38
CHOOSING AMONG THESE MODELS
For specific combinations of exposures and outcomes, evidence on which 
of the lifecourse models is most appropriate is drawn from both theoretical 
considerations and empirical analyses. The models have divergent 
implications regarding the statistical associations between early and midlife 
exposures and the outcome. The statistical implications of each model can 
be read off the diagrams and thus used to empirically assess the plausibility 
of each model.12 For example, an implication of the latency model in 
Figure 1d is that midlife cognitive stimulation should have no relationship 
to probability of dementia after controlling for childhood educational 
exposures. In other words, in the model:
Probability(dementia) = c
0 
+ c
1 
* X
1 
+ c
2 
* X
2  
the coefficient c
2
 should be null, while the coefficient c
1
 should predict 
dementia. If both exposures were measured perfectly and there were no 
confounders of either the childhood or the adult risk factor, this finding 
would rule out the immediate risk, social trajectory, or cumulative risk 
models. Alternatively, if we found that both childhood and midlife 
exposures were independently predictive of the outcome, this would be 
inconsistent with the immediate risk, social trajectory, or latency models 
and instead suggest that a cumulative effects model characterized the 
relationship between the risk factor and the outcome.
Unfortunately, the assumptions under which this approach succeeds are 
very stringent and rarely completely credible. Available measures of 
childhood conditions are invariably inadequate and many studies also have 
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imperfect measures of the adult risk factor.39 Further, if childhood conditions 
influence adult conditions (as in the social trajectory model) then these 
analyses entail all of the challenges of direct/indirect effects decomposition.38-40 
Finally, testing effects of mobility versus effects of beginning or final 
position is challenging because of the colinearity between any two of these, 
given the third. For example, adult socioeconomic status is exactly 
determined by childhood socioeconomic status plus change in socioeconomic 
status from childhood to adulthood.38 Convincing solutions have not been 
developed, but advances may come from substantive assumptions about 
possible mediators of effects; and or about the functional relationship 
between any of the three and the outcome.41-43 
EXPANDING THESE FRAMEWORKS TO DISTINGUISH  
DEVELOPMENT FROM DISEASE
Many important health conditions, including dementia and disability, 
reflect the intersection of developmental processes, pathological or disease 
processes, and recovery or resilience. These three components may have 
distinct antecedents. The criteria for clinical diagnoses of Alzheimer’s 
disease include a threshold component based on deficits in specific 
cognitive domains.44 Although most diagnostic criteria include consideration 
of whether the deficit represents a decline from prior functioning, ceiling 
effects in currently used measurement scales make it difficult to identify 
deficits in very high performing individuals. As a result, deficits are 
intrinsically related to performance below a threshold.
Whether or not a person performs below a cognitive threshold may be 
influenced by attained cognitive skills (e.g., IQ), a pathologic process (e.g., 
ischemia induced neural damage or deposition of amyloid plaques) in the 
brain, or cognitive plasticity or resilience that enables maintenance of 
function even after an individual incurs neurologic damage. For example, 
Figure 2a contrasts two very different hypothetical lifecourse cognitive 
trajectories. For both individuals, cognitive performance meets the criteria 
for dementia at the same age. However, one individual experienced a longer 
period of cognitive development in early life, and then a much faster rate of 
decline, perhaps due to a more severe or aggressive type of dementia. The 
other individual ceased enhancement of cognitive skills relatively early in 
life, but then experienced a slow rate of cognitive decline during old age. 
Modeling age of dementia diagnosis (or risk of dementia diagnosis) does 
not fully distinguish between these two distinct pathways. Similarly, in 
Figure 2b, one cognitive trajectory reflects a series of mild strokes, each 
496 Public Health Reviews, Vol. 32, No 2
causing modest cognitive decrements, with essentially no post-stroke 
cognitive recovery. The other trajectory reflects a series of severe strokes, 
each followed by substantial cognitive recovery. These two individuals 
meet the threshold for dementia at roughly the same time, but the factors 
that influenced the severity of stroke versus stroke recovery are probably 
quite different.
Fig. 2. Alternative cognitive trajectories across the lifecourse, resulting in meeting 
threshold criteria at the same age. (a) Longer period of cognitive development but 
faster rate of age-related decline. (b) More severe cognitive decrements after stroke, 
but greater neurologic recovery.
Conversion to a clinically recognized dementia is an important outcome 
to the extent that this is the point where individuals are likely to lose 
independence, require greater services, and place greater burden on 
caregivers. Such considerations lead clinicians naturally to focus research 
on the endpoint of dementia diagnosis. However, defining diagnosis as the 
outcome of interest forces unnecessary and unrealistic assumptions about 
the nature of the disease under study. Dementia is a spectrum disorder, and 
the identification of cases involves applying arbitrary thresholds to a 
continuous process.45 Both the major underlying pathologies that are 
understood to cause dementia and cognitive decline, and the behavioral 
manifestation of those pathologies, are exhibited quantitatively.46 Even 
individuals with low cognitive scores within the “normal” range are at 
elevated risk of mortality and institutionalization,47,48 suggesting the 
underlying biological process of cognitive decline may best be characterized 
as a continuous – instead of a threshold – marker of risk. Breaking a 
continuous outcome into discrete categories through the application of 
arbitrary thresholds, even if clinically well-informed, is often bad statistical 
practice.49 Moreover, conflation of the outcome in this way is likely to 
create unnecessary barriers to identifying exposures that influence either 
cognitive development or the disease process that results in decline. This is 
especially problematic in the case of dementia, because normal variability 
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in cognitive test performance among adults is much larger than variability 
in the rate of decline or disease development.
Longitudinal study designs combined with analyses examining changes 
in indicators of disease or functional outcomes are a better option. Lifecourse 
models can reflect the distinct influences of developmental processes, disease 
processes, and recovery/resilience. These models explicitly represent the 
hypothesized causal mechanism linking any specific risk factor to dementia. 
Often, early life factors are likely to influence late life disease because of 
their effects on development, and therefore vulnerability to physiologic 
insults encountered later in life. Figure 3 shows one possible model, in which 
early life conditions directly influence neurologic development and also the 
development of certain types of neurologic disease, but do not directly affect 
recovery/resilience. 
Fig. 3. Lifecourse model distinguishing between developmental, pathological, and 
recovery processes linking education or cognitive engagement to dementia.
In this hypothetical model, adult cognitive stimulation influences 
recovery after neurologic injury, but has no direct effect on either early life 
neurologic development or the risk of developing pathologies that harm 
cognitive function (e.g., Alzheimer’s or cerebrovascular disease). This model 
shows the co-occurrence of stimulation and pathology as a single variable on 
the pathway between cognitive stimulation and cognitive recovery. This is to 
represent the (testable) hypothesis that cognitive stimulation is only 
important in the context of injury or disease.50 This diagram also illustrates a 
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serious potential bias in lifecourse research: early indicators of disease may 
influence exposure to risk factors, for example, if small cognitive impairments 
in early stages of dementia lead individuals to withdraw from cognitively 
challenging activities. These expanded models can be valuable for research 
on many types of complex health conditions because they express and 
illustrate how to empirically test hypothesized causal mechanisms by which 
lifecourse risk factors affect the outcome. We now turn to discussing how 
recognition of lifecourse factors can inform research on adult risk factors 
and adult disease.
POTENTIAL FOR CONFOUNDING BY EARLY LIFE CONDITIONS
Confounding bias arises when there is a common cause of the exposure and 
outcome variables.51-53 For example, in Figure 1d, we would say that 
childhood education confounds the association between adult cognitive 
stimulation and dementia, because childhood education influences both, 
but the effect of education is not mediated by adult cognitive stimulation. 
Early life conditions are possible confounders in chronic disease research, 
because childhood exposures are often strong predictors of adult risk 
factors, such as socioeconomic position (SEP), diet and other behaviors,54-56 
and cardiovascular and immune function,4,57-59 all factors believed to be 
important in determining cognitive performance level in later life. In most 
studies, childhood conditions are either measured poorly or not measured 
at all. If one were attempting to test a social trajectory versus cumulative 
effects model, for example, the adequacy of measurement of early and late 
life exposures is critical. Often early life exposures are measured with 
relatively more error than late life exposures. Thus, parameter estimates for 
early life exposures will be biased towards the null, leading to a risk of 
spuriously rejecting the cumulative effects model in favor of the social 
trajectory model. The proliferation of longitudinal studies with multiple 
measures of the same construct (e.g., SEP) across time may help address 
the problem.35,60 However, even with operational measures of early-life 
conditions, fully eliminating confounding bias depends on accurately 
modeling the cascade of “upstream” lifecourse exposures that influence 
adult risk factors and health outcomes.30
THE IMPORTANCE OF MODELING CHANGE INSTEAD OF LEVEL
As suggested by the discussion above and Figure 2, the findings of 
lifecourse epidemiology imply that if we are interested in identifying 
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determinants of the pathological process (e.g., plaque deposition), the 
appropriate outcomes are markers of the pathological process. Exclusive 
use of cognitive performance at any given age, or even “onset” of disease 
as a surrogate outcome is a weak design because there are many influences 
other than pathology that contribute to variability in performance. Rather, 
to study the development of pathologies related to aging, it is important to 
focus on indicators of the accumulation of pathology. This is often 
impractical, and therefore studies of changes in performance across time 
may be a suitable endpoint. Although disease onset may appear to 
intrinsically correspond with a change in function, this is often misleading. 
Many diseases have roots years, decades, or even generations prior to the 
date of diagnosis or even the earliest clinical symptoms.
A leading hypothesized mechanism linking education and dementia is 
that education may reduce risk of manifesting cognitive impairment in the 
face of a given level of neuropathology.59,60 Education probably affects 
neurologic development61,62 and cognitive skills may likewise influence 
attained education. But this association tells us little about the etiology of, 
for example, amyloid plaques. In research on the development of age-
related pathology, the effects of education on early life cognitive function 
may simply be “noise.” However, the developmental effects of education 
are likely to be huge,61,63-65 so this noise is a serious impediment to research.
In a community population of middle-aged or “young-old” individuals, 
the cognitive performance differences associated with an attained year of 
education are sometimes several times as large as the cognitive performance 
differences associated with a chronological year of age (calculations 
available from the authors). Age-related change becomes more important 
among older samples, but even in quite aged populations, a great deal of the 
cross-sectional variance in cognitive function is attributable to stable 
personal characteristics such as education.
Focusing on cognitive decline or change may also help avoid conflation 
of cohort differences with aging effects. Conceptually, a birth cohort 
represents a unique social category. The life chances of individuals within 
a birth cohort will be affected by intra-cohort characteristics (e.g., 
demographic composition of the cohort), inter-cohort characteristics (e.g., 
relative size compared to other generations). Longitudinal studies have 
reported significant cohort differences in baseline cognitive performance, 
such that successive generations appear to have better cognitive test 
performance, differences which are not fully attributable to schooling.66-68 
In cross-sectional designs, this pattern will tend to overstate the effect of 
aging because older individuals differ from younger individuals in both age 
and birth cohort. It is necessary to examine rate of change to understand the 
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effects of aging per se. Although there may be differences in rate of 
cognitive decline across cohorts, evidence for this is much more mixed.67,69,70
Cognitive decline may also be a better predictor of subsequent physical 
outcomes than cognitive level, due to the improved capacity to capture 
change over time.71,72 Given the dynamic nature of cognitive functioning, 
there may be substantial measurement errors in cognitive function measured 
cross-sectionally. Cognitive trajectories may be a more accurate 
characterization of the ongoing process of cognitive aging. Conversely, 
maintenance of cognitive function, even relatively low but stable function, 
may be reflective of a successful cognitive aging trajectory. With threshold-
based outcomes such as onset of dementia, healthy individuals with low but 
largely stable cognitive function may be categorized as demented with only 
a small decrement in performance due to a transient factor.
Insufficient analytic distinctions between determinants of development 
and determinants of disease may have contributed to the longstanding 
debate regarding the effects of education on dementia and cognitive aging. 
A first generation of studies found that education predicted higher baseline 
cognition levels, reduced risk of cognitive impairment (performance below 
a threshold), and reduced risk of dementia in the elderly.73-84 Results from a 
number of early studies suggested that education slowed the rate of 
cognitive decline.85 However, these results were challenged by several 
subsequent reports using improved longitudinal methods, and the overall 
association is now in question.8,9,86-89 Change-point models that flexibly 
model rate of decline prior to the formal diagnosis of dementia indicate that 
the association between education and level of function might be in the 
opposite direction as the association between education and rate of change.90
Despite the above discussion, in some cases, level of functioning is more 
substantively important than rate of change. For example, projections of disease 
burden and assessments of individual clinical needs may need to incorporate 
information on diagnoses and other criteria based on level of performance.91
LIFELONG ACCUMULATION OF RISK CONTRIBUTES  
TO SELECTION AND SURVIVOR BIAS IN STUDIES OF AGING
Studies of early life determinants of adult health are potentially subject to 
severe bias from selective survival: the early life adversity may influence 
the chance of surviving to old age, so the only elderly who experienced 
extreme childhood adversity are those with some other protective factor.39 
In extreme forms this phenomena has been called “reverse epidemiology”.92 
This bias can also apply to adult risk factors, and is thought to account for 
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the mixed findings regarding the association between cigarette smoking 
and dementia among older adults. This association generally attenuates in 
older samples, presumably because the lethality of smoking results in 
highly winnowed populations of very old smokers.93 In the example of 
education and cognitive function, education promotes survival, and thus 
low-education elderly may have other unobserved, beneficial personal 
traits. If these traits influence health, they would bias any estimate of the 
association between education and health among the survivors. Because of 
the association between education and cognitive engagement, the same 
bias may apply to estimates of the association between adult cognitive 
activities and health. Such selection bias can be addressed analytically 
using common missing data methods such as inverse probability weighting 
to account for competing risks if the other factors are measured.94,95 In 
many instances, it has been shown that although this bias is a theoretical 
possibility, it is not severe unless survival is quite low (e.g., in very old 
samples). Studies of individuals above age 80 or 90, however, may face 
severe bias due to selective survival.
HETEROGENEOUS EXPOSURE EFFECTS FOR DETERMINANTS 
OF ADULT HEALTH
The vast majority of biomedical research focuses on the effects of treatment 
on the population average health (either overall average or within specified 
population subgroups). However, there is no reason to assume that exposure 
has the same effect on everyone in a population, or even everyone within a 
pre-specified subgroup.96 There is growing recognition that focusing 
exclusively on average effects may be misleading and inappropriate.97,98 We 
do not expect medical interventions to affect all individuals similarly: we 
take it for granted that medical treatments are targeted to those individuals 
most likely to benefit (e.g., anti-hypertensive medications are given to 
individuals with hypertension, not normotensive individuals). The field of 
personalized genetics is premised on the hope that there are many heretofore 
unmeasured genetic characteristics that determine treatment responsiveness.
Extending this idea to social conditions, we can see that unmeasured 
social risk factors may also modify the effects of exposure for any type of 
adult risk factor. Early life adversity may exert an influence on health and 
well-being throughout life so that individuals who arrive at old age as “low 
performers” may already have experienced a very distinct life history of 
adverse social conditions prior to the initiation of a study. These exposures 
may modify the response of the individual to new exposures or treatments. 
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As a result, when considering any adult risk factor, the effects on “high 
performers” may be very different than the effects on “low performers”. For 
example, aging may result in faster cognitive decline among “low performers” 
who are already at risk in late middle-age, and have less severe affects on 
“high performers” who arrive at late middle-age with a lifelong cumulative 
advantage. Modeling this heterogeneity can be challenging. For example, 
our ability to detect differences in the pace of cognitive change over time 
requires cognitive outcome measures with interval level scaling properties. 
Brief mental status tests and single domain assessments rarely satisfy such 
strict requirements. If such measures were available, we would anticipate an 
increasing variability in cognitive function across age, as in Figure 4.
Fig. 4. Individuals who experience advantage across life and arrive at middle age 
with high cognitive function may experience cognitive decline more slowly than 
those who encounter disadvantage across life. If so, this will result in greater 
increasing variability in cognitive function across age.
The standard approach to examine possible variation in exposure effects 
is to include an interaction between the exposure and observed covariates 
(e.g., low socioeconomic status as a child) in the regression model. At the 
very least, current studies using interaction terms to assess heterogeneity in 
average exposure effects should conduct and report subgroup analyses 
(with appropriate account for multiple testing).99 However, treatment 
responsiveness may differ across unmeasured or unknown personal traits. 
There are alternative methods that can explicitly model heterogeneous 
treatment effects on high and low baseline performers, without explicitly 
specifying interaction models. Quantile regression models can be used to 
describe the effect of the risk factor on the entire distribution of the outcome, 
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rather than just the mean as in conventional ordinary least squares regression 
models. One study using quantile regression found variations in the 
association between early life influences and adult body mass index (BMI). 
Among smaller women, birth weight was strongly associated with adult 
BMI while maternal weight gain was strongly associated with adult BMI 
among larger women.100 Arguably, individuals at the extreme end of the 
cognitive distribution are of greater concern for population health than 
individuals at the mean. Furthermore, rate of change for any given percentile 
may be dependent on that percentile. To date, no studies have considered 
how cognitive trajectories might differ for those at different parts of the 
distribution. Since continuous measures are generally more sensitive to 
group differences than categorical outcomes, quantile methods may also 
better capture differences in associations between various risk factors and 
continuous measure of cognition.
CONCLUSIONS AND FUTURE RESEARCH DIRECTIONS
A large body of evidence now indicates that many adult chronic diseases 
are shaped by early life exposures. Although the importance of a lifecourse 
approach to understanding chronic disease is increasingly recognized, 
public health interventions applying these principles have been limited. 
When designing interventions, it is valuable to clearly articulate the 
lifecourse model assumed to link the exposure and the outcome, and 
identify lifecourse periods when the exposure can be changed. If there is a 
single early life sensitive period for a specific exposure-outcome 
combination, it may be useless to initiate interventions later in life. If harm 
accumulates slowly throughout life, interventions to change exposure in 
adulthood may take years before they show benefits. Explicit recognition of 
lifecourse models can help improve design and effectiveness of future 
intervention programs to promote healthy aging.7 Public health interventions 
informed by a lifecourse perspective have focused on time points presumed 
to have special plasticity, such as early childhood. Researchers have 
advocated that maternal and child health interventions using a lifecourse 
approach include: 1) information strategies that use age-appropriate 
messages and venues to disseminate health information across the lifespan; 
2) administrative strategies that link health services across the life span; 
3) organizational strategies that reconfigure programs to reflect integrated 
health goals and 4) environmental strategies that address community 
building and environmental exposure.101-104 Early Childhood Comprehensive 
Systems enacted by several US states already incorporate a lifecourse 
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perspective and use such a multi-pronged approach.105 Recent developments 
in trials of pharmaceutical treatments for Alzheimer’s disease, such as 
amyloid immunotherapy, suggest that intervening early may be essential. 
Treatments may be most effective at interrupting the neuropathological 
process long before conventional diagnostic criteria are met, although the 
optimal timing is unknown.106 The public health challenge is to improve our 
understanding of the lifecourse processes linking modifiable exposures and 
major diseases and use this information to inform effective interventions 
across the lifespan. Although preventive interventions early in life may 
have larger benefits than comparable interventions later in the lifecourse for 
some outcomes, most adult health outcomes presumably reflect an ongoing 
interplay between biological, environmental and social factors. Emerging 
evidence suggests physiologic and functional plasticity in many domains 
persists throughout life.107-109 Interventions targeting time points in mid or 
late adulthood may clearly have substantial benefits.
Articulating and applying theoretical models of lifecourse processes 
(e.g., immediate risk, social trajectory, cumulative effects, latency, or 
mobility) to longitudinal data can help clarify interpretation and comparison 
of regression results. Even when the focus of research is late life risk 
factors, it is important to consider the role of lifecourse processes in 
generating the observed associations between the risk factor and the 
outcome; creating barriers to intervention efforts to remediate the risk 
factor; or modifying the responsiveness of individuals to the risk factor. 
Explicit theorizing about lifecourse processes will help inform better 
intervention design, even when the intervention is for older adults.7 Finally, 
lifecourse models are important as we project into the future the health of 
an aging population and consider priorities for current health investments. 
In coming years, we may experience either substantial health benefits or 
health costs due to investments made during the early lives of aging cohorts. 
Likewise, investments made now in generations of children or younger 
adults may have health consequences for decades into the future.
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